Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees

Vaccine

Volumn 16, Issue 19, 1998, Pages 1836-1841

  Bagarazzi, Mark L ^a   Boyer, Jean D ^b   Ugen, Kenneth E ^c   Javadian, M Ali ^d   Chattergoon, Michael ^b   Shah, Ami ^b   Bennett, Mosi ^b   Ciccarelli, Richard ^e   Carrano, Richard ^e   Coney, Leslie ^e   Weiner, David B ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d Alamogordo Primate Facility   (United States)

^e Apollon Inc   (United States)

Author keywords

Antibody; CTL; Flow cytometry; Gene; Immunization; Lymphocyte proliferation; Mucosal; Plasmid; Primate

Indexed keywords

DNA; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELLULAR IMMUNITY; CHIMPANZEE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOTHERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

AIDS VACCINES; ANIMALS; DISEASE MODELS, ANIMAL; DNA, VIRAL; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; LYMPHOCYTE SUBSETS; MALE; PAN TROGLODYTES; PREGNANCY; VACCINES, DNA;

EID: 0032210889     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00178-9     Document Type: Conference Paper

References (20)

1. 1 Cohen, J. AIDS research: the mood is uncertain. Science 1993, 260, 1254-1255.
2. 2 Davis, H.L, Michel, M.L and Whalen, R.G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Human Mol Genetics 1993, 2, 1847-1851.
3. 3 Lu, S., Santoro, J.C., Fuller, D.H., Haynes, J.R. and Robinson, H.L. Use of DNAs expressing HIV-1 env and non-infectious HIV-1 particles to raise antibody responses in mice. Virology 1995, 209, 147-154.
4. 4 Tang, D.C., Devit, M. and Johnson, S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 1992, 356, 152-154.
5. 5 Ulmer, J.B., Donnelly, J., Parker, S.E., Rhodes, G.H., Felgner, P.L, Dwarki, V.J., Gromkowski, S.H., Deck, R.R., DeWitt, C.M., Friedman, A., Hawe, L.A., Leander, K.R., Martinez, D., Perry, H.C., Shiver, J.W., Montgomery, D.L. and Liu, M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749.
6. 6 Wang, B., Ugen, K.E., Srikantan, V., Agadjanyan, M.G., Dang, K., Refaeli, Y., Sato, A., Boyer, J.D., Williams, W.V. and Weiner, D.B. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993, 90, 4156-4160.
7. 7 Wang, B., Boyer, J.D., Srikantan, V., Ugen, K.E., Gilbert, L., Phan, C., Dang, K., Merva, M., Agadjanyan, M.G., Newman, M., Carrano, R., McCallus, D., Coney, L., Williams, W.V. and Weiner, D.B. Induction of humoral and cellular immune responses to the human immunodeficiency type-1 virus in non-human primates by in vivo DNA inoculation. Virology 1995, 211, 102-112.
8. 8 Boyer, J.D., Wang, B., Ungen, K., Agadjanyan, M.G., Javadian, M.A., Frost, P., Dang, K., Carrano, R., Ciccarelli, R., Coney, L., Williams, W.V. and Weiner, D.B. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol 1996, 25, 242-250.
9. 9 Coney, L., Wang, B., Ugen, K.E., Boyer, J.D., McCallus, D., Srikantan, V., Agadjanyan, M.G., Pachuk, C.J., Herold, K., Merva, M., Gilbert, L., Dang, K., Moelling, K., Newman, M., Williams, W.V. and Weiner, D.B. Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo. Vaccine 1994, 12, 1545-1550.
10. 10 Bagarazzi, M., Boyer, J.D., Javadian, M.A., Chattergoon, M.A., Dang, K., Koo, G., Shah, J., Wang, B. and Weiner, D.B. Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees. J Med Primatol 1997, 26, 27-33.
11. 11 Boyer, J.D., Ugen, K.E., Wang, B., Agadjanyan, M.G., Gilbert, L., Bagarazzi, M.L., Chattergoon, M., Frost, P., Javadian, M.A., Williams, W.V., Refaeli, Y., Ciccarelli, R.B., McCallus, D., Coney, L. and Weiner, D.B. Protection of chimpanzees from high dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 1997, 3, 526-532.
12. 12 Kim, J.J., Ayyavoo, V., Bagarazzi, M.L., Chattergoon, M.A., Dang, K., Wang, B., Boyer, J.D. and Weiner, D.B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol 1997, 158, 816-826.
13. 13 Boyer, J.D., Ugen, K.E., Chattergoon, M., Wang, B., Shah, A., Agadjanyan, M.G., Bagarazzi, M.L., Javadian, M.A., Carrano, R., Coney, L., Williams, W.V., Weiner, D.B. DNA vaccination as anti-HIV immunotherapy in infected chimpanzees. J Inf Dis 176 (in press).
14. 14 Ugen, K., Boyer, J.D., Wang, B., Bagarazzi, M.L., Javadian, M.A., Frost, P., Merva, M.M., Nyland, S., Williams, W.V., Coney, L., Ciccarelli, R. and Weiner, D.B. Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial. Vaccine 1997, 15, 927-930.
15. 15 Girard, M., Meignier, B., Barre-Sinoussi, F., Kieny, M.-P., Matthews, T., Muchmore, E., Nara, P.L., Wei, Q., Rimsky, L., Weinhold, K. and Fultz, P.N. Vaccine-induced ptection of chimpanzees against infection by a heterologous human immunodeficiency virus type-1. J Virol 1995, 69, 6239-6248.
16. 16 Cheng-Mayer, C., Homsy, J., Evans, L.A. and Levy, J.A. Identification of human immunodeficiency virus subtypes and distinct patterns of sensitivity to serum neutralization, Proc Natl Acad Sci USA 1988, 85, 2815-2819.
17. 17 Katzenstein, D.A., Vujcic, L.K., Latif, A., Boulos, R., Halsey, N.A, and Quinn, T.C. et al. Human immunodeficiency neutralizing antibodies in sera from North Americans and Africans emergence of neutralization. J Acquir Immune Syndr 1990, 3, 810-816.
18. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type-1 infection. J Virol 1994, 68, 6103-6110.
19. 19 Koup, R.A., Safrit, J.T. and Cao, Y. et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type-1 syndrome. J Virol 1994, 68, 4650-4655.
20. mac32H(J5). J Virol 1995, 69, 6289-6296.